Learn More
Invitrogen™ F(ab)-Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor™ Plus 405
Description
F(ab)-Goat anti-Rabbit IgG (H+L) Superclonal™ Recombinant Secondary Antibody, Alexa Fluor™ Plus 405 can detect both Rabbit Fab2 and Fc fragment of Rabbit IgG. It showed no cross-reactivity to various species immunoglobulins tested. This Fab fragment antibody is expressed in vitro and purified as a recombinant construct. It is also engineered to deliver enhanced stability and sensitivity. The advantages of recombinant antibodies include-better specificity, animal origin-free formulation, and lot-to-lot consistency. F(ab) fragments offer several advantages over full-length IgGs due to their smaller molecular size (~50 kDa vs. ~150 kDa), such as improved tissue penetration. The absence of the Fc region reduces nonspecific binding and background staining in Fc receptor-expressing cells and tissues, while also enabling increased flexibility in multiplexing assays. Alexa Fluor™ Plus dyes have been chemically optimized to provide higher signal to noise ratios and minimized cross-reactivity to help detect low-abundance targets in rare or precious samples. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
Specifications
Specifications
| Antigen | Rabbit IgG (H+L) |
| Applications | Immunocytochemistry |
| Classification | Recombinant Superclonal |
| Concentration | 1 mg/mL |
| Conjugate | Alexa Fluor Plus 405 |
| Formulation | Proprietary buffer with 0.008% Bromonitrodioxane, 0.008% Methylisothiazolone; pH 6.3-7.3 |
| Host Species | Goat |
| Immunogen | Purified Rabbit IgG. |
| Purification Method | Affinity chromatography |
| Quantity | 250 μL |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.